Rivastigmine Transdermal System 51991-0897-30

Generic: Rivastigmine

Package NDC

51991-0897-30

Product NDC: 51991-0897

Manufacturer: Breckenridge Pharmaceutical, Inc.
Dosage Form: Patch, Extended Release
Route: Transdermal
Product Type: Human Prescription Drug
Marketing Start: December 19, 2019
Listing Expires: December 31, 2026
Application: ANDA209063

Need to source Rivastigmine Transdermal System? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Rivastigmine	4.6 mg/24h

Drug Class

Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]

Selected Package

51991-0897-30Selected

30 POUCH in 1 CARTON (51991-897-30) / 1 PATCH in 1 POUCH (51991-897-99) / 24 h in 1 PATCH